Hydralazine HCL is a direct-acting vasodilator used in the treatment of hypertension and heart failure. Manufactured by BLUEPILL EXPRESS under WHO-GMP conditions, this high-quality API is available for global third-party supply and pharmaceutical formulation.

Hydralazine Hydrochloride (Hydralazine HCL) is a potent antihypertensive API used to manage moderate to severe essential hypertension, particularly in combination therapies. It acts as a direct arterial vasodilator, reducing peripheral resistance and improving cardiac output. It is also used in treating heart failure and hypertensive emergencies, including those in pregnancy such as pre-eclampsia and eclampsia.

At BLUEPILL EXPRESS, we offer premium-grade Hydralazine HCL API for third-party manufacturing and global supply. Produced in WHO-GMP and ISO-certified manufacturing facilities, our Hydralazine HCL meets international pharmacopeial standards (IP/BP/USP/EP) and is tested rigorously for purity, assay, stability, and microbial limits.

Direct vasodilator API used for hypertension and heart failure

WHO-GMP certified manufacturing under BLUEPILL EXPRESS

Available in bulk for third-party production and formulation

High-purity material with full quality and regulatory documentation

Suitable for tablets and injectable formulations

Essential Hypertension (second-line agent)

Hypertensive Emergency

Pre-eclampsia and Eclampsia

Congestive Heart Failure (in combination therapy)

Our manufacturing infrastructure ensures batch-to-batch consistency, fast production timelines, and flexible MOQs to suit every pharmaceutical partner. We support our clients with all necessary documentation, including Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), stability data, and DMF support on request.

Whether you are producing finished formulations for domestic markets or exporting under government healthcare contracts, BLUEPILL EXPRESS delivers quality-driven, regulatory-compliant Hydralazine API to meet global demand.